As of 2025-05-29, the Relative Valuation of Ginkgo Bioworks Holdings Inc (DNA) is (208.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.42 USD, the upside of Ginkgo Bioworks Holdings Inc based on Relative Valuation is -2907.2%.
The range of the Relative Valuation is (176.56) - (228.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 23.0x | 19.7x |
| Forward P/E multiples | 17.8x - 26.8x | 22.3x |
| Fair Price | (176.56) - (228.14) | (208.30) |
| Upside | -2479.5% - -3174.6% | -2907.2% |
| Date | P/E |
| 2025-05-28 | -0.75 |
| 2025-05-27 | -0.68 |
| 2025-05-23 | -0.70 |
| 2025-05-22 | -0.69 |
| 2025-05-21 | -0.75 |
| 2025-05-20 | -0.81 |
| 2025-05-19 | -0.82 |
| 2025-05-16 | -0.80 |
| 2025-05-15 | -0.77 |
| 2025-05-14 | -0.79 |
| 2025-05-13 | -0.82 |
| 2025-05-12 | -0.84 |
| 2025-05-09 | -0.78 |
| 2025-05-08 | -0.79 |
| 2025-05-07 | -0.75 |
| 2025-05-06 | -0.65 |
| 2025-05-05 | -0.70 |
| 2025-05-02 | -0.71 |
| 2025-05-01 | -0.70 |
| 2025-04-30 | -0.74 |
| 2025-04-29 | -0.74 |
| 2025-04-28 | -0.81 |
| 2025-04-25 | -0.79 |
| 2025-04-24 | -0.79 |
| 2025-04-23 | -0.77 |
| 2025-04-22 | -0.76 |
| 2025-04-21 | -0.74 |
| 2025-04-17 | -0.79 |
| 2025-04-16 | -0.82 |
| 2025-04-15 | -0.83 |
| 2025-04-14 | -0.84 |
| 2025-04-11 | -0.82 |
| 2025-04-10 | -0.74 |
| 2025-04-09 | -0.68 |
| 2025-04-08 | -0.58 |
| 2025-04-07 | -0.65 |
| 2025-04-04 | -0.56 |
| 2025-04-03 | -0.57 |
| 2025-04-02 | -0.60 |
| 2025-04-01 | -0.57 |
| 2025-03-31 | -0.57 |
| 2025-03-28 | -0.62 |
| 2025-03-27 | -0.66 |
| 2025-03-26 | -0.67 |
| 2025-03-25 | -0.72 |
| 2025-03-24 | -0.78 |
| 2025-03-21 | -0.73 |
| 2025-03-20 | -0.72 |
| 2025-03-19 | -0.75 |
| 2025-03-18 | -0.73 |